A61L27/446

WATER-SOLUBLE SALT PARTICLE CONTAINING COMPOSITIONS AND POROUS MATERIALS MADE THEREFROM
20240100226 · 2024-03-28 ·

Compositions for forming porous materials and three-dimensional objects, including fibers, films and coatings made from the materials are provided. Also provided are methods for forming the porous objects from the compositions. The compositions include a solvent, a polymer binder that is soluble in the solvent, and solid particles that are insoluble in the solvent. The solid particles include water-soluble salt particles that can be selectively dissolved from objects made from the compositions to render the resulting structures porous.

WATER-SOLUBLE SALT PARTICLE CONTAINING COMPOSITIONS AND POROUS MATERIALS MADE THEREFROM
20240100226 · 2024-03-28 ·

Compositions for forming porous materials and three-dimensional objects, including fibers, films and coatings made from the materials are provided. Also provided are methods for forming the porous objects from the compositions. The compositions include a solvent, a polymer binder that is soluble in the solvent, and solid particles that are insoluble in the solvent. The solid particles include water-soluble salt particles that can be selectively dissolved from objects made from the compositions to render the resulting structures porous.

COMPOSITION FOR PRODUCING A BONE REPLACEMENT MATERIAL, METHOD FOR PRODUCING A PHARMACEUTICAL EXCIPIENT, PHARMACEUTICAL EXCIPIENT, AND USE THEREOF
20240091416 · 2024-03-21 ·

A composition for producing a bone replacement material, which composition reacts with water or an aqueous solution in a cementitious setting reaction and forms a solid body. Additionally disclosed is a method for producing a pharmaceutical excipient having the aforementioned composition, the pharmaceutical excipient produced in this way, and the use of such a composition or such a pharmaceutical excipient for the local release of at least one pharmaceutical active ingredient.

COMPOSITION FOR PRODUCING A BONE REPLACEMENT MATERIAL, METHOD FOR PRODUCING A PHARMACEUTICAL EXCIPIENT, PHARMACEUTICAL EXCIPIENT, AND USE THEREOF
20240091416 · 2024-03-21 ·

A composition for producing a bone replacement material, which composition reacts with water or an aqueous solution in a cementitious setting reaction and forms a solid body. Additionally disclosed is a method for producing a pharmaceutical excipient having the aforementioned composition, the pharmaceutical excipient produced in this way, and the use of such a composition or such a pharmaceutical excipient for the local release of at least one pharmaceutical active ingredient.

AN IMPLANT COMPRISING MAGNESIUM ALLOY AND A METHOD FOR PREPARING THEREOF
20240050623 · 2024-02-15 ·

The present application provides an implant comprising magnesium alloy comprising Ca in the range of 0.3-2 wt %, Zn in the range of 0.5-6 wt %, Fe in the range of 50-100 ppm, and Zr in the range of 100-900 ppm and total impurities including Fe and Zr in the range of 400-1000 ppm. The present application also provides a method for preparing an implant, the method comprising providing biodegradable magnesium alloy having an average grain size of 40 ?m or less and comprising Ca in the range of 0.3-2 wt %, Zn in the range of 0.5-6 wt %, Fe in the range of 50-100 ppm, and Zr in the range of 100-900 ppm and total impurities including Fe and Zr in the range of 400-1000 ppm, and forming the biodegradable magnesium alloy into the implant.

AN IMPLANT COMPRISING MAGNESIUM ALLOY AND A METHOD FOR PREPARING THEREOF
20240050623 · 2024-02-15 ·

The present application provides an implant comprising magnesium alloy comprising Ca in the range of 0.3-2 wt %, Zn in the range of 0.5-6 wt %, Fe in the range of 50-100 ppm, and Zr in the range of 100-900 ppm and total impurities including Fe and Zr in the range of 400-1000 ppm. The present application also provides a method for preparing an implant, the method comprising providing biodegradable magnesium alloy having an average grain size of 40 ?m or less and comprising Ca in the range of 0.3-2 wt %, Zn in the range of 0.5-6 wt %, Fe in the range of 50-100 ppm, and Zr in the range of 100-900 ppm and total impurities including Fe and Zr in the range of 400-1000 ppm, and forming the biodegradable magnesium alloy into the implant.

Water-soluble salt particle containing compositions and porous materials made therefrom

Compositions for forming porous materials and three-dimensional objects, including fibers, films and coatings made from the materials are provided. Also provided are methods for forming the porous objects from the compositions. The compositions include a solvent, a polymer binder that is soluble in the solvent, and solid particles that are insoluble in the solvent. The solid particles include water-soluble salt particles that can be selectively dissolved from objects made from the compositions to render the resulting structures porous.

Water-soluble salt particle containing compositions and porous materials made therefrom

Compositions for forming porous materials and three-dimensional objects, including fibers, films and coatings made from the materials are provided. Also provided are methods for forming the porous objects from the compositions. The compositions include a solvent, a polymer binder that is soluble in the solvent, and solid particles that are insoluble in the solvent. The solid particles include water-soluble salt particles that can be selectively dissolved from objects made from the compositions to render the resulting structures porous.

Borate-glass biomaterials

Borate-glass biomaterials comprising: aNa.sub.2O. bCaO. cP.sub.2O.sub.5. dB.sub.2O.sub.3 wherein a is from about 1-40 wt %, b is from about 10-40 wt %, c is from about 1-40 wt %, and d is from about 35-80 wt %; and wherein the biomaterial has a surface area per mass of more than about 5 m.sup.2/g. Methods of making and uses of these biomaterials.

Borate-glass biomaterials

Borate-glass biomaterials comprising: aNa.sub.2O. bCaO. cP.sub.2O.sub.5. dB.sub.2O.sub.3 wherein a is from about 1-40 wt %, b is from about 10-40 wt %, c is from about 1-40 wt %, and d is from about 35-80 wt %; and wherein the biomaterial has a surface area per mass of more than about 5 m.sup.2/g. Methods of making and uses of these biomaterials.